SeCure trial data show ablation of incompetent perforator veins benefits patients

17949

Kathleen Gibson (Bellevue, USA), one of the principal investigators of the SeCure trial, presented its results at the ACP 2018 annual congress. “More than closure rates, it is the quality of life findings from this trial that are important take-homes for physicians,” Gibson told Venous News.


LEAVE A REPLY

Please enter your comment!
Please enter your name here